Objective: This study aimed to develop a protocol to screen and monito
r patients with diabetic macular thickening using optical coherence to
mography (OCT), a technique for high-resolution cross-sectional imagin
g of the retina. Design: A cross-sectional pilot study was conducted.
Participants: A total of 182 eyes of 107 patients with diabetic retino
pathy, 55 eyes from 31 patients with diabetes but no ophthalmoscopic e
vidence of retinopathy, and 73 eyes from 41 healthy volunteers were st
udied. Intervention: Six optical coherence tomograms were obtained in
a radial spoke pattern centered on the fovea. Retinal thickness was co
mputed automatically from each tomogram at a total of 600 locations th
roughout the macula. Macular thickness was displayed geographically as
a false-color topographic map and was reported numerically as average
s in each of nine regions. Main Outcome Measures: Correlation of OCT w
ith slit-lamp biomicroscopy, fluorescein angiography, and visual acuit
y was measured. Results: Optical coherence tomography was able to quan
tify the development and resolution of both foveal and extrafoveal mac
ular thickening. The mean +/- standard deviation foveal thickness was
174 +/- 18 mu m in normal eyes, 179 +/- 17 mu m in diabetic eyes witho
ut retinopathy, and 256 +/- 114 mu m in eyes with nonproliferative dia
betic retinopathy. Foveal thickness was highly correlated among left a
nd right eyes of normal eyes (mean +/- standard deviation difference o
f 6 +/- 9 mu m). Foveal thickness measured by OCT correlated with visu
al acuity (r(2) = 0.79). A single diabetic eye with no slit-lamp evide
nce of retinopathy showed abnormal foveal thickening on OCT. Conclusio
ns: Optical coherence tomography was a useful technique for quantifyin
g macular thickness in patients with diabetic macular edema. The topog
raphic mapping protocol provided geographic information on macular thi
ckness that was intuitive and objective.